Q3 results: Johnson & Johnson beats estimates on demand for cancer drug Reuters Oct 19, 2022 The company said it expects some impact of inflation to ease next year but higher costs of inventory manufactured in 2022 could…
Hester Biosciences announces Q3 and 9M FY22 results EP News Bureau Feb 1, 2022 Sales up by nine per cent and 23 per cent for Q3 and 9M FY22, respectively
Eris Lifesciences Q3FY22 revenues at Rs 3,322 million, up seven per cent YoY EP News Bureau Jan 31, 2022 The company's EBITDA stood at Rs 1,217 million, up 13.5 per cent YoY and PAT stood at Rs 1,008 million, up 11.8 per cent YoY
Torrent Pharma December quarter profit slips 16 per cent to Rs 249 crores Press Trust of India Jan 27, 2022 The drugmaker had posted a net profit of Rs 297 crores in the October-December period of the 2020-21 fiscal